Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
Company registration number: 06561294 Charity number: 1130823
TRUSTEES' REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 JUNE 2024
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
CONTENTS
| Page | |
|---|---|
| Reference and administrative details of the Charity, its Trustees and advisers | 1 |
| Trustees' report | 2 - 5 |
| Independent auditors' report on the financial statements | 6 - 9 |
| Consolidated statement of financial activities | 10 |
| Consolidated balance sheet | 11 |
| Charity balance sheet | 12 |
| Consolidated statement of cash flows | 13 |
| Notes to the financial statements | 14 - 26 |
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 30 JUNE 2024
Trustees Timothy John Regan (resigned 30 November 2024) Professor Otavio Berwanger Da Silva Professor Alankar Anushka Patel Justin Ooi (appointed 30 November 2024)
Company registered number 06561294
Charity registered number 1130823 Registered office Magna House 18-32 London Road Staines-Upon-Thames Surrey TW18 4BP
Executive Director Professor Otavio Berwanger Da Silva
Independent auditors Menzies LLP Chartered Accountants Statutory Auditor Magna House 18-32 London Road Staines-Upon-Thames Surrey TW18 4BP
Page 1
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
TRUSTEES' REPORT FOR THE YEAR ENDED 30 JUNE 2024
The Trustees present their annual report together with the audited financial statements of The George Institute for Global Health (UK) for the year 1 July 2023 to 30 June 2024. The annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102).
Since the Charity qualifies as small under section 382 of the Companies Act 2006, the strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.
Reference and administrative details
Reference and administrative details are shown in the schedule of officers and professional advisers on page 1 of the financial statements.
Objectives and activities
Policies and objectives
The charity's objectives are the advancement of education and the preservation and protection of the good health of the public.
The charity’s short and long-term objectives are focused on:
-
improving the health of disadvantaged populations worldwide;
-
better management of common chronic and critical conditions;
-
innovation to ensure the sustainability of healthcare services; and
-
new approaches to managing injury, frailty and disability across the globe.
This is achieved by undertaking clinical, epidemiological and health systems research, especially focused on reducing the burden of chronic diseases and injuries.
In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.
Achievements and performance
The charity continued to operate and incurred various costs in relation to the following principal activities that contributed to the objectives:
-
The gaining of peer-reviewed research grants in the UK, and global funding bodies;
-
To attract and retain academic talent and to expand local support from corporate services;
-
The conduct of high-impact research on chronic diseases (such as cardiometabolic conditions, multimorbidity and kidney disease), women’s health, and injury. The main types of studies conducted included health systems research, clinical trials and observational studies;
-
The publication of scientific papers in prestigious peer-reviewed journals such as The Lancet, British Medical Journal (BMJ), New England Journal of Medicine, Nature, Journal of the American Medical Association (JAMA), among others; and presentation of research findings in major international scientific conferences;
-
Efforts to ensure the translation of research findings into clinical guidelines, policies from governments and healthcare authorities and clinical practice;
-
To expand the involvement of patient and public (including underserved communities) in our research;
-
To establish new national and international academic partnerships.
Page 2
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2024
Performance indicators include the following financial and non-financial targets:
-
The number and value of peer-reviewed research grants;
-
The number of scientific papers in prestige peer-reviewed journals;
-
The growth in revenue of clinical, epidemiological and health system research; and
-
Financial sustainability as measured by the dollar value of surplus, cash, net current assets and total net asset.
Financial review
Operations
The George institute reported total consolidated revenue of £2,401,464 (2023: £1,009,809). This represents an increase in unrestricted income of £1,210,342 (2023: £883,856) received from the charity’s parent company to fund operations. Income includes restricted grant income of £283,321 (2023: nil) and non-charitable trading activities from George Partners of £23,945 (2023: £132,159). Residual activities carried out by the charity’s trading subsidiary George Partners Limited have now been transferred to the charity and the intention is to make this company dormant by 30 June 2025. Total consolidated expenditure for the year was £2,395,469. The net result for the group was a small surplus of £5,995 (30 June 2023: £6,989).
Net group assets at year-end were £131,449.
The principal risks and uncertainties facing the charity and its undertakings, as identified by the charity trustees, include the following:
-
The inability to deliver pivotal research;
-
The inability to attract and retain world class researchers;
-
The inability to source adequate funding; and
-
The inability to incorporate research findings into public policy and practice
A risk mitigation strategy has been designed for each of the strategic risks above which includes:
-
Recruiting world class researchers who are experts in chronic diseases and injury;
-
Providing competitive salaries and flexible working conditions;
-
Applying for diversified funding sources in the UK and globally; and
-
Establishing an Impact & Engagement team who advocate and promote the research findings.
Going concern
After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future given the support of the parent organisation. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.
Reserves policy
At the year end the group had total funds of £131,449 which were unrestricted. The charity had negative unrestricted reserves at year end of £11,664 and is dependent on the support of its parent charity. Consideration will however be given to establishing a reserves policy appropriate to the charity’s future activities.
Structure, governance and management
The charity is established as a company limited by guarantee and is governed by the Memorandum and Articles of Association as revised dated 21 September 2011. It is under the control of the Board of Trustees. New Trustees are appointed by the Board of Trustees.
Page 3
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2024
The trustees
The trustees who served the company during the period were as follows:
-
T J Regan (resigned 30 November 2024)
-
Professor A A Patel
-
Professor O Berwanger Da Silva
-
Justin Ooi ( appointed 30 November 2024)
The general aims and objectives of the charity are set by the trustees and then implemented by the charity’s paid staff. The charity is lead by an Executive Director who in turn reports to the CEO of parent entity, The George Institute for Global Health.
New Trustees are already Trustees or employees of the global group and have a thorough understanding of the group’s operations. The Trustees attend regular executive meetings and are members of the global Executive Leadership Team.
Salaries are set by reference to benchmarks for employees carrying out similar roles within the medical research community. Input is received form the Global Chief People Officer and Imperial College London.
The charity works closely with its parent organisation, The George Institute in Australia, and represents the activity of the group in the UK. The charity also works closely in collaboration with Imperial College, London who the charity has an academic affiliation with.
Plans for future periods
The charity is aiming to grow its activities in the UK and its association with Imperial College, London. It is actively seeking to increase its grant funding from third parties and to expand its areas of research activities in the UK and globally. The charity will be the sole vehicle for growing the global organisation’s activities in the UK in its endeavour to achieve its mission of “improving the health of millions worldwide”.
Statement of Trustees' responsibilities
The Trustees (who are also the directors of the Charity for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles of the Charities SORP (FRS 102);
-
make judgements and accounting estimates that are reasonable and prudent;
-
state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Page 4
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2024
Disclosure of information to auditors
Each of the persons who are Trustees at the time when this Trustees' report is approved has confirmed that: so far as that Trustee is aware, there is no relevant audit information of which the charity's auditors are unaware, and that Trustee has taken all the steps that ought to have been taken as a Trustee in order to be aware of any relevant audit information and to establish that the charity's auditors are aware of that information.
Auditors
Under section 487(2) of the Companies Act 2006, Menzies LLP will be deemed to have been reappointed as auditors 28 days after these financial statements were sent to members or 28 days after the latest date prescribed for filing the accounts with the registrar, whichever is earlier.
Small companies note
In preparing this report, the directors have taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.
Approved by order of the members of the board of Trustees and signed on their behalf by:
................................................ Justin Ooi Trustee
Date: 26-Mar-2025
Page 5
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK)
Opinion
We have audited the financial statements of The George Institute for Global Health (UK) (the 'parent charitable company') and its subsidiaries (the 'group') for the year ended 30 June 2024 which comprise the Consolidated statement of financial activities, the Consolidated balance sheet, the Charity balance sheet, the Consolidated statement of cash flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
-
give a true and fair view of the state of the Group's and of the parent charitable company's affairs as at 30 June 2024 and of the Group's incoming resources and application of resources, including its income and expenditure for the year then ended;
-
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-
have been prepared in accordance with the requirements of the Companies Act 2006 and the Charities Act 2011.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.
Page 6
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (CONTINUED)
Other information
The other information comprises the information included in the Annual report other than the financial statements and our Auditors' report thereon. The Trustees are responsible for the other information contained within the Annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinion on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
-
the information given in the Trustees' report for the financial year for which the financial statements are prepared is consistent with the financial statements.
-
the Trustees' report has been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees' report.
We have nothing to report in respect of the following matters in relation to which Companies Act 2006 requires us to report to you if, in our opinion:
-
the parent charitable company has not kept adequate and sufficient accounting records, or returns adequate for our audit have not been received from branches not visited by us; or
-
the parent charitable company financial statements are not in agreement with the accounting records and returns; or
-
certain disclosures of Trustees' remuneration specified by law are not made; or
-
we have not received all the information and explanations we require for our audit; or
-
the Trustees were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemptions in preparing the Trustees' report and from the requirement to prepare a Strategic report.
Responsibilities of trustees
As explained more fully in the Trustees' responsibilities statement, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the Trustees are responsible for assessing the Group's and the parent charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the Group or the parent charitable company or to cease operations, or have no realistic alternative but to do so.
Page 7
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (CONTINUED)
Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
-
The charitable company is subject to laws and regulations that directly affect the financial statements including financial reporting legislation. We determined that the following laws and regulations were most significant including FRS 102, Charities SORP, Companies Act 2006, Charities Act 2011 and employment law. We assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statement items.
-
The engagement partner assessed whether the engagement team collectively had the appropriate competence and capabilities to identify or recognise non-compliance with laws and regulations. The assessment did not identify any issues in this area.
-
We understood how the charitable company is complying with those legal and regulatory frameworks by, making inquiries of management and those responsible for legal and compliance procedures.
We assessed the susceptibility of the charitable company’s financial statements to material misstatement, including how fraud might occur. We considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the following areas; management override of controls to manipulate results, or to cause the charitable company to enter into transactions not in its best interests.
Audit procedures performed by the engagement team included:
-
Identifying and assessing the design effectiveness of controls management has in place to prevent and detect fraud;
-
Understanding how those charged with governance considered and addressed the potential for override of controls or other inappropriate influence over the financial reporting process; and
-
Reviewing all transactions accounted for during the year.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' report.
Page 8
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (CONTINUED)
Use of our report
This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006, and to the charitable company's trustees, as a body, Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an Auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its members, as a body, for our audit work, for this report, or for the opinions we have formed.
Janice Matthews FCA (Senior Statutory Auditor) for and on behalf of Menzies LLP Chartered Accountants Statutory Auditor Magna House 18-32 London Road Staines-Upon-Thames Surrey TW18 4BP
Date: 26-Mar-2025
Page 9
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 30 JUNE 2024
| Note Income from: Donations and legacies 3 Other trading activities 4 Total income Expenditure on: Raising funds 5 Charitable activities 6 Total expenditure Net (expenditure)/income Transfers between funds 14 Net movement in funds Reconciliation of funds: Total funds brought forward Net movement in funds Total funds carried forward |
Unrestricted funds 2024 £ 2,094,198 23,945 2,118,143 17,950 2,136,876 2,154,826 (36,683) 42,678 5,995 125,454 5,995 131,449 |
Restricted funds 2024 £ 283,321 - 283,321 - 240,643 240,643 42,678 (42,678) - - - - |
Total funds 2024 £ 2,377,519 23,945 2,401,464 17,950 2,377,519 2,395,469 5,995 - 5,995 125,454 5,995 131,449 |
As restated Total funds 2023 £ 883,856 132,159 1,016,015 |
|---|---|---|---|---|
| 125,170 883,856 1,009,026 |
||||
| 6,989 - 6,989 |
||||
| 118,465 6,989 125,454 |
Page 10
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee) REGISTERED NUMBER: 06561294
CONSOLIDATED BALANCE SHEET AS AT 30 JUNE 2024
| Note Current assets Debtors 12 Cash at bank and in hand Creditors: amounts falling due within one year 13 Net current assets Total assets less current liabilities Total net assets Charity funds Restricted funds 14 Unrestricted funds 14 Total funds |
242,018 101,215 343,233 (211,784) |
2024 £ 131,449 131,449 131,449 - 131,449 131,449 |
306,039 12,931 318,970 (193,516) |
2023 £ 125,454 |
|---|---|---|---|---|
| 125,454 | ||||
| 125,454 | ||||
| - 125,454 |
||||
| 125,454 |
The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.
The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.
The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:
................................................
Justin Ooi
Trustee Date: 26-Mar-2025
The notes on pages 14 to 26 form part of these financial statements.
Page 11
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee) REGISTERED NUMBER: 06561294
CHARITY STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2024
| Note Fixed assets Investments 11 Current assets Debtors 12 Cash at bank and in hand Creditors: amounts falling due within one year 13 Net current liabilities Total assets less current liabilities Net liabilities excluding pension asset Total net assets Charity funds Restricted funds 14 Unrestricted funds 14 Total funds |
202,207 40,158 242,365 (254,030) |
2024 £ 1 1 (11,665) (11,664) (11,664) (11,664) - (11,664) (11,664) |
248,684 11,911 260,595 (272,260) |
2023 £ 1 1 (11,665) (11,664) (11,664) (11,664) - (11,664) (11,664) |
|---|---|---|---|---|
The Charity's net movement in funds for the year was £NIL (2023 - £NIL).
The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.
The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.
The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:
................................................
Justin Ooi Date: 26-Mar-2025
The notes on pages 14 to 26 form part of these financial statements.
Page 12
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 30 JUNE 2024
| Cash flows from operating activities Net cash used in operating activities Cash flows from investing activities Net cash provided by investing activities Cash flows from financing activities Net cash provided by financing activities Change in cash and cash equivalents in the year Cash and cash equivalents at the beginning of the year Cash and cash equivalents at the end of the year |
2024 £ 88,284 - - 88,284 12,931 101,215 |
2023 £ (1,667) - - (1,667) 14,598 12,931 |
|---|---|---|
The notes on pages 14 to 26 form part of these financial statements
Page 13
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
1. General information
The George Institute for Global Health (UK) is a private charitable company limited by guarantee incorporated in England and Wales, registered number 06561294. Details of its principle activities and registered office are set out in the reference and administration details in the Trustees' Report on pages 1 and 2.
2. Accounting policies
2.1 Basis of preparation of financial statements
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standards applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standards applicable in the UK and Ireland (FRS 102) and the Companies Act 2006.
The Charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
The Consolidated statement of financial activities (SOFA) and Consolidated balance sheet consolidate the financial statements of the Charity and its subsidiary undertaking. The results of the subsidiary are consolidated on a line by line basis.
The Charity has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of financial activities in these financial statements.
2.2 Going concern
The Trustees have received assurances that the Parent Charity will continue to support the UK Charity to enable it to pay its costs as these arise for at least twelve months from the date of approval of these financial statements and for the foreseeable future. These accounts are accordingly prepared on the Going Concern basis.
2.3 Income
All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
Grants are included in the Consolidated statement of financial activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.
Page 14
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
2. Accounting policies (continued)
2.4 Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.
Expenditure on charitable activities is incurred on directly undertaking the activities which further the Group's objectives, as well as any associated support costs.
All expenditure is inclusive of irrecoverable VAT.
2.5 Investments
Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Consolidated statement of financial activities.
Investments in subsidiaries are valued at cost less provision for impairment.
2.6 Liabilities and provisions
Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.
2.7 Operating leases
Rentals paid under operating leases are charged to the Consolidated statement of financial activities on a straight-line basis over the lease term.
2.8 Pensions
The Group operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Group to the fund in respect of the year.
2.9 Fund accounting
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Group and which have not been designated for other purposes.
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Group for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.
Page 15
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
| 3. Income from donations and legacies Grants Total 2023 as restated 4. Income from other trading activities Income from non charitable trading activities Sales 5. Expenditure on raising funds Other trading expenses Subsidiary company administration expenses |
Unrestricted funds 2024 £ 2,094,198 883,856 |
Restricted funds 2024 £ 283,321 - Unrestricted funds 2024 £ 23,945 Unrestricted funds 2024 £ 17,950 |
Total funds 2024 £ 2,377,519 883,856 Total funds 2024 £ 23,945 Total funds 2024 £ 17,950 |
As restated Total funds 2023 £ 883,856 |
|---|---|---|---|---|
| Total funds 2023 £ 132,159 |
||||
| Total funds 2023 £ 125,170 |
Page 16
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
| 6. Analysis of expenditure on charitable activities Summary by fund type Medical Research Total 2023 as restated 7. Analysis of expenditure by activities Medical Research |
Unrestricted funds 2024 £ 2,136,876 883,856 |
Restricted funds 2024 £ 240,643 - Support costs 2024 £ 2,377,519 |
Total 2024 £ 2,377,519 883,856 Total funds 2024 £ 2,377,519 |
As restated Total 2023 £ 883,856 |
|---|---|---|---|---|
| As restated Total funds 2023 £ 883,856 |
Page 17
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
7. Analysis of expenditure by activities (continued)
Analysis of support costs
| Medical Research 2024 £ Staff costs 1,680,783 Recruitment costs 16,745 Staff training 36,310 Insurance 1,743 IT costs 25,633 Consultancy fees 206,949 Bank charges 3,353 Conference costs 716 Payroll and filing fees 5,520 Rent 254,433 Repair & Maintenance 1,986 Subscriptions & Memberships 2,465 Other costs 3,321 Accommodation and travel 93,784 Entertainment 2,118 Professional fees 40,772 Apprenticeship levy 888 2,377,519 8. Auditors' remuneration Fees payable to the Charity's auditor for the audit of the Charity's annual accounts Fees payable to the Charity's auditor in respect of: All non-audit services not included above |
Total funds 2024 £ 1,680,783 16,745 36,310 1,743 25,633 206,949 3,353 716 5,520 254,433 1,986 2,465 3,321 93,784 2,118 40,772 888 2,377,519 2024 £ 10,350 5,750 |
As restated Total funds 2023 £ 618,636 15,296 5,585 134 518 74,390 385 470 3,912 133,270 2,880 102 - 15,306 34 12,488 450 883,856 |
|---|---|---|
| 2023 £ 4,550 2,200 |
Page 18
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
9. Staff costs
| Group Group As restated Charity 2024 2023 2024 £ £ £ Wages and salaries 1,343,203 510,589 1,343,203 Social security costs 156,586 52,436 156,586 Contribution to defined contribution pension schemes 180,994 55,611 180,994 1,680,783 618,636 1,680,783 The average number of persons employed by the Charity during the year was as follows: Group Group As restated Charity 2024 2023 2024 No. No. No. Employees 28 11 24 |
Charity As restated 2023 £ 510,589 52,436 55,611 |
|---|---|
| 618,636 | |
| Charity As restated 2023 No. 9 |
The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:
| Group | Group | |
|---|---|---|
| 2024 | 2023 | |
| No. | No. | |
| In the band £60,001 - £70,000 | 1 | 1 |
| In the band £100,001 - £110,000 | 2 | - |
| In the band £110,001 - £120,000 | 1 | - |
| In the band £120,001 - £130,000 | 1 | - |
| In the band £130,001 - £140,000 | 1 | - |
Other than the salary of Professor Otavio Berwanger Da Silva for acting as Chief Executive (see below), the UK charity does not employ Key Management Personnel. Management services are provided to the UK charity by the Australian parent charity, for which no charge is made.
Page 19
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
10. Trustees' remuneration and expenses
During the year, a Trustee has been paid remuneration from an employment with the Charity for their role as Chief Executive. This remuneration was permitted under the company's Articles. No amounts have been paid in respect of acting as a Trustee. The value of Trustees' remuneration and other benefits was as follows:
| As restated | |||
|---|---|---|---|
| 2024 | 2023 | ||
| £ | £ | ||
| Professor Otavio Berwanger Da Silva | Remuneration | 104,301 | 26,052 |
| During the year ended 30 June 2024, no Trustee expenses have been incurred(2023 - £NIL). |
11. Fixed asset investments
| Charity Cost or valuation At 1 July 2023 At 30 June 2024 Net book value At 30 June 2024 At 30 June 2023 |
Investments in subsidiary companies £ 1 |
|---|---|
| 1 | |
| 1 | |
| 1 |
Page 20
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
12. Debtors
| Due within one year Trade debtors Amounts owed by group undertakings Other debtors Prepayments and accrued income Creditors: Amounts falling due within one year Trade creditors Amounts owed to group undertakings Other taxation and social security Other creditors Accruals and deferred income |
Group 2024 £ 6,900 121,690 - 113,428 242,018 Group 2024 £ 39,484 - 71,195 19,068 82,037 211,784 |
Group 2023 £ - 175,559 37,255 93,225 306,039 Group 2023 £ 83,969 11,561 39,121 13,448 45,417 193,516 |
Charity 2024 £ 6,900 81,879 - 113,428 202,207 Charity 2024 £ 39,484 87,917 39,219 19,068 68,342 254,030 |
Charity 2023 £ - 171,959 - 76,725 |
|---|---|---|---|---|
| 248,684 | ||||
| Charity 2023 £ 83,969 109,327 31,290 13,448 34,226 |
||||
| 272,260 |
13. Creditors: Amounts falling due within one year
Page 21
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
14. Statement of funds
Statement of funds - current year
| Unrestricted funds General Funds George Partners Restricted funds Swedish Government Grant Welcome Trust Grant Total of funds Statement of funds - prior year Unrestricted funds General Funds - all funds George Partners |
Balance at 1 July 2023 £ (11,664) 137,118 125,454 - - - 125,454 |
Income £ 2,094,198 23,945 2,118,143 128,456 154,865 283,321 2,401,464 Balance at 1 July 2022 £ (11,664) 130,129 118,465 |
Expenditure £ (2,136,876) (17,950) (2,154,826) (128,456) (112,187) (240,643) (2,395,469) As restated Income £ 883,856 132,159 1,016,015 |
Transfers in/out £ 42,678 - 42,678 - (42,678) (42,678) - As restated Expenditure £ (883,856) (125,170) (1,009,026) |
Balance at 30 June 2024 £ (11,664) 143,113 131,449 - - - 131,449 Balance at 30 June 2023 £ (11,664) 137,118 125,454 |
|---|---|---|---|---|---|
Page 22
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
15. Analysis of net assets between funds
Analysis of net assets between funds - current period
| Current assets Creditors due within one year Total Analysis of net assets between funds - prior period Current assets Creditors due within one year Total |
Unrestricted funds 2024 £ 343,233 (211,784) 131,449 Unrestricted funds 2023 £ 318,970 (193,516) 125,454 |
Total funds 2024 £ 343,233 (211,784) 131,449 Total funds 2023 £ 318,970 (193,516) 125,454 |
|---|---|---|
16. Reconciliation of net movement in funds to net cash flow from operating activities
| Net income for the period (as per Statement of Financial Activities) Adjustments for: Decrease/(increase) in debtors Increase in creditors Net cash provided by/(used in) operating activities |
Group 2024 £ 5,995 64,021 18,268 88,284 |
Group 2023 £ 6,989 (148,586) 139,930 (1,667) |
|---|---|---|
Page 23
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
17. Analysis of cash and cash equivalents
| Cash in hand Total cash and cash equivalents |
Group 2024 £ 101,215 101,215 |
Group 2023 £ 12,931 |
|---|---|---|
| 12,931 |
18. Analysis of changes in net debt
| Cash at bank and in hand | At 1 July 2023 £ 12,931 12,931 |
Cash flows £ 88,284 88,284 |
At 30 June 2024 £ 101,215 101,215 |
|---|---|---|---|
19. Operating lease commitments
At 30 June 2024 the Group and the Charity had commitments to make future minimum lease payments under noncancellable operating leases as follows:
| Charity | Charity | |||
|---|---|---|---|---|
| 2024 | 2023 | |||
| £ | £ | |||
| Not later than | 1 | year | 51,084 | - |
20. Members' liability
Each member of the charitable company undertakes to contribute to the assets of the company in the event of it being wound up while he/she is a member, or within one year after he/she ceases to be a member, such amount as may be required, not exceeding £NIL for the debts and liabilities contracted before he/she ceases to be a member.
Page 24
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
21. Related party transactions
At 30 June 2024 the charitable company owed £87,917 (2023: £109,327) to its subsidiary company George Partners Limited. During the year George Partners Limited incurred rechargable rental charges of £75,585 (2023: £43,800) on behalf of the company.
At 30 June 2024 the charitable company was owed £59,624 (2023: £168,176) by its parent company The George Institute for Global Health (Australia) and £Nil (2023: £3,783) by George Health Enterprises UK Limited and £6,070 by George Medicines UK Limited, other members of the group headed by The George Institute for Global Health (Australia). Grant income of £2,094,198 (2023: £883,856) was payable by the The George Institute for Global Health (Australia) and recharged costs of £Nil (2023: £3,783) to George Health Enterprises UK Limited and £20,889 (2023: £Nil) to George Medicines UK Limited.
22. Controlling party
The George Institute for Global Health (UK) is a subsidiary of The George Institute for Global Health, a charitable body registered in Australia, by virtue of the terms of the Articles of Association. The Australian Business Number (ABN) for The George Institute for Global Health is 90 085 953 331.
The principle activity of The George Institute for Global Health is to undertake clinical, epidemiological and health systems research, especially focused on reducing the burden of chronic diseases and injuries.
The smallest group for which consolidated financial statements are drawn up is The George Institute for Global Health. The address of the charity is Level 18, International Towers 3,300 Barangaroo Avenue, Sydney, NSW, 2000, Australia.
23. Principal subsidiaries
The following was a subsidiary undertaking of the Charity:
Name Company Registered office or principal Principal activity number place of business George Partners Limited 07277904 Magna House Medical research 18-32 London Road Staines-Upon-Thames TW18 4BP
The financial results of the subsidiary for the year were:
| Name | Profit for the | Net assets |
|---|---|---|
| year | £ | |
| £ | ||
| George Partners Limited | 5,995 | 143,114 |
The company holds one ordinary share being 100% of the issued share capital of George Partners Limited.
Page 25
Docusign Envelope ID: 9215824A-7B8B-4C9C-BA66-7BECF5E88588
THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
24. Prior year adjustment
The income and expenditure of the preceding period have both been increased by £92,750 to recognise the costs of staff provided to the charity by a third party but invoiced to the ultimate parent charity. There is no net change to the surplus of the preceding period.
Page 26